Aehr Test Systems (NASDAQ:AEHR – Get Free Report) Director Laura Oliphant sold 1,717 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $133.00, for a total transaction of $228,361.00. Following the completion of the sale, the director directly owned 16,100 shares in the company, valued at $2,141,300. This represents a 9.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Aehr Test Systems Stock Performance
Aehr Test Systems stock opened at $134.06 on Friday. Aehr Test Systems has a 1 year low of $16.38 and a 1 year high of $147.40. The firm has a 50 day moving average price of $92.83 and a 200 day moving average price of $71.45. The company has a market cap of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10.
Institutional Trading of Aehr Test Systems
Large investors have recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of Aehr Test Systems by 2.2% during the fourth quarter. Vanguard Group Inc. now owns 2,337,433 shares of the semiconductor company’s stock worth $47,193,000 after purchasing an additional 49,243 shares in the last quarter. Halter Ferguson Financial Inc. boosted its stake in shares of Aehr Test Systems by 41.7% in the fourth quarter. Halter Ferguson Financial Inc. now owns 642,129 shares of the semiconductor company’s stock valued at $12,965,000 after purchasing an additional 189,117 shares during the period. State of Alaska Department of Revenue acquired a new stake in Aehr Test Systems during the 4th quarter valued at $377,000. UBS Group AG grew its holdings in Aehr Test Systems by 55.7% during the 4th quarter. UBS Group AG now owns 243,129 shares of the semiconductor company’s stock valued at $4,909,000 after purchasing an additional 87,014 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Aehr Test Systems during the 4th quarter worth $407,000. Institutional investors and hedge funds own 69.69% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Report on Aehr Test Systems
Aehr Test Systems News Roundup
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
- Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
- Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
- Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation
About Aehr Test Systems
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Further Reading
- Five stocks we like better than Aehr Test Systems
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
